The official blog of the Lung Institute.

What is My Why? Jessica Reed

28 Feb 2018
| Under Featured | Posted by
What Is My Why? Jessica Reed

A featured series where Lung Institute employees tell their stories #WhatIsMyWhy

Before coming to the Lung Institute, I didn’t realize how many people suffer from lung disease and how it affects their day-to-day activities.

I came from a family-practice setting and regularly saw patients with COPD. It was difficult to realize that for many of them their only option was to carry on with their current inhaler regimen even though they were continuing to have shortness of breath symptoms.

Success at Any Age

A younger patient initially came to us using oxygen regularly when going to the mall or any outside trips. She looked pale and down. Six months later she came back for her follow up appointment and she had a bright smile on her face and renewed color in her cheeks.

She looked happy and full of life. She then regaled me with the story that she can now go to the mall for a few hours without her oxygen and now she doesn’t even think about it when she leaves the house. Before treatments, she made sure her oxygen was always by her side just in case.

Give Hope and Offer Quality

I am a nurse practitioner and the director of clinical operations, so I oversee all clinic locations nationally.

I came to the Lung Institute in 2014 and continue working here to remain part of a team that provides a new, innovative medical treatment, and I look forward to helping more patients in the future.

I love the idea of providing patients with another treatment option outside the traditional prescription medications. I am inspired to come to work because on any day I may get to hear from a patient who is now able to go out shopping without oxygen, and now has a different outlook, a smile on her face and an improved quality of life.


* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.